Cosmos Health (NASDAQ:COSM) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 91.11 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $19.703 million which beat the analyst consensus estimate of $18.821 million by 4.69 percent. This is a 38.52 percent increase over sales of $14.224 million the same period last year.